Liver resection in obesity patients
Editorial

Liver resection in obesity patients

Kenei Furukawa ORCID logo, Koichiro Haruki, Tomohiko Taniai, Mitsuru Yanagaki, Toru Ikegami

Division of Hepatobiliary and Pancreas Surgery, Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan

Correspondence to: Kenei Furukawa, MD. Division of Hepatobiliary and Pancreas Surgery, Department of Surgery, The Jikei University School of Medicine, 3-25-8, Mishi-shinbashi, Minato-ku, Tokyo 105-8461, Japan. Email: k-furukawa@jikei.ac.jp.

Comment on: Kampf S, Sponder M, Fitschek F, et al. Obesity and its influence on liver dysfunction, morbidity and mortality after liver resection. Hepatobiliary Surg Nutr 2023;12:704-14.


Keywords: Liver resection; colorectal liver metastases (CRLM); obesity


Submitted Nov 19, 2024. Accepted for publication Dec 11, 2024. Published online Jan 15, 2025.

doi: 10.21037/hbsn-2024-657


We enjoyed the article by Kampf et al. (1) on obesity and its association with fatty liver and post-hepatectomy liver failure (PHLF). They concluded that obesity, defined by body mass index (BMI), was associated with liver steatosis and fibrosis; however, postoperative complications, including PHLF after liver resection, were comparable regardless of BMI, suggesting that liver resection is safely performed in obese patients. However, the surgical method for obese patients is also important, and Inoue et al. have reported that open liver resection for colorectal liver metastases (CRLM) in obese patients resulted in a significantly higher risk of infectious complications than laparoscopic liver resection (2).

As the authors mentioned in the limitations section, obesity was assessed using BMI in this study, but other assessments (waist circumference and body composition) need to be considered. Moreover, fatty liver was assessed by pathological evaluation of the resected liver specimens, which cannot be assessed preoperatively.

We conducted the analyses in 167 patients who underwent hepatectomy for CRLM at our institute between May 2007 and December 2021. BMI was the most useful assessment for diagnosing fatty liver by preoperative computed tomography (CT) (3) (Table 1). Therefore, we are in favor of assessing obesity using the BMI, which is widely available and easy to evaluate.

Table 1

Diagnostic performance for fatty liver

Variables AUC P value
BMI 0.793 <0.01
Waist circumference 0.779 <0.01
SFA 0.692 <0.01
VFA 0.785 <0.01
VFA/SFA ratio 0.570 0.30

AUC, area under the curve; BMI, body mass index; SFA, subcutaneous fat area; VFA, visceral fat area.

Although obesity appears to be associated with a higher risk of postoperative complications after liver surgery, there is no consensus regarding its effect on long-term outcomes. Generally, postoperative complications contribute to poor long-term outcomes (4). However, some studies have reported the protective effects of obesity on long-term outcomes (5,6). In our cohort, among the various obesity assessments, only high waist circumference was a significantly favorable prognostic factor for overall survival (Table 2).

Table 2

Univariate analysis in relation to overall survival according to obesity after hepatectomy for colorectal liver metastases

Variables OS univariate analysis
Hazard ratio (95% CI) P value
BMI, high 0.71 (0.36–1.40) 0.32
Waist circumference, high 0.58 (0.35–0.96) 0.04
SFA, high 0.96 (0.58–1.57) 0.86
VFA, high 1.02 (0.62–1.67) 0.95
VFA/SFA ratio 1.11 (0.67–1.84) 0.68

OS, overall survival; CI, confidence interval; BMI, body mass index; SFA, subcutaneous fat area; VFA, visceral fat area.

As the rate of obesity increases worldwide, it is important to consider liver resection in patients with obesity. In addition, we should return to the basics and reaffirm the importance of evaluating obesity based on BMI and waist circumference, which do not require special testing equipment, rather than body composition using CT and body composition analyzers.


Acknowledgments

Funding: None.


Footnote

Provenance and Peer Review: This article was commissioned by the editorial office, HepatoBiliary Surgery and Nutrition. The article did not undergo external peer review.

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://hbsn.amegroups.com/article/view/10.21037/hbsn-2024-657/coif). The authors have no conflicts of interest to declare.

Ethical Statement: The authors are accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.


References

  1. Kampf S, Sponder M, Fitschek F, et al. Obesity and its influence on liver dysfunction, morbidity and mortality after liver resection. Hepatobiliary Surg Nutr 2023;12:704-14. [Crossref] [PubMed]
  2. Inoue Y, Ishii M, Fujii K, et al. Safety and Efficacy of Laparoscopic Liver Resection for Colorectal Liver Metastasis With Obesity. Am Surg 2021;87:919-26. [Crossref] [PubMed]
  3. Pickhardt PJ, Park SH, Hahn L, et al. Specificity of unenhanced CT for non-invasive diagnosis of hepatic steatosis: implications for the investigation of the natural history of incidental steatosis. Eur Radiol 2012;22:1075-82. [Crossref] [PubMed]
  4. Matsuda A, Matsumoto S, Seya T, et al. Does postoperative complication have a negative impact on long-term outcomes following hepatic resection for colorectal liver metastasis?: a meta-analysis. Ann Surg Oncol 2013;20:2485-92. [Crossref] [PubMed]
  5. Kim JM, Chung E, Cho ES, et al. Impact of subcutaneous and visceral fat adiposity in patients with colorectal cancer. Clin Nutr 2021;40:5631-8. [Crossref] [PubMed]
  6. Kamada T, Ohdaira H, Takahashi J, et al. Effect of low visceral fat area on long-term survival of stage I-III colorectal cancer. Nutrition 2024;118:112302. [Crossref] [PubMed]
Cite this article as: Furukawa K, Haruki K, Taniai T, Yanagaki M, Ikegami T. Liver resection in obesity patients. Hepatobiliary Surg Nutr 2025;14(1):109-110. doi: 10.21037/hbsn-2024-657

Download Citation